Qinghai Spring Medicinal Resources Technology Co., Ltd.
Shanghai Stock ExchangeTotal Valuation
Qinghai Spring Medicinal Resources Technology Co., Ltd. carries a market capitalization of 2.82B, placing it among publicly traded companies globally. Its enterprise value stands at 1.53B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.82B |
| Enterprise Value | 1.53B |
Share Statistics
Qinghai Spring Medicinal Resources Technology Co., Ltd. currently has 587.06M shares outstanding.
| Shares Outstanding | 587.06M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 7.82, and the price-to-book ratio stands at 2.52.
| PE Ratio | N/A |
| PS Ratio | 7.82 |
| PB Ratio | 2.52 |
| P/TBV Ratio | 1.83 |
| P/FCF Ratio | 524.27 |
| P/OCF Ratio | N/A |
Enterprise Valuation
| EV / Sales | 7.09 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 440.74 |
Financial Position
Qinghai Spring Medicinal Resources Technology Co., Ltd. maintains a current ratio of 17.66, meaning it holds 17.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.26, indicating conservative leverage, while an interest coverage ratio of -90.72 demonstrates limited ability to service its debt obligations.
| Current Ratio | 17.66 |
| Quick Ratio | 4.57 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | -0.15 |
| Interest Coverage | -90.72 |
Financial Efficiency
| Return on Equity (ROE) | -8.34 |
| Return on Assets (ROA) | -5.46 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -15.52 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.86 |
Taxes
Over the trailing twelve months, Qinghai Spring Medicinal Resources Technology Co., Ltd. has paid 13.69M in income taxes, reflecting an effective tax rate of 587.86.
| Income Tax | 13.69M |
| Effective Tax Rate | 587.86 |
Stock Price Statistics
Qinghai Spring Medicinal Resources Technology Co., Ltd.'s stock has gained approximately 16% over the past 52 weeks. The 50-day moving average sits at 4.83, while the 200-day moving average is 4.18.
| Beta (5Y) | N/A |
| 52-Week Price Change | 16% |
| 50-Day Moving Average | 4.83 |
| 200-Day Moving Average | 4.18 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Qinghai Spring Medicinal Resources Technology Co., Ltd. generated 216.01M in revenue and converted that into -58.37M in net income, yielding earnings per share of -0.10. EBITDA reached -17.68M, while operating income came in at -17.68M.
| Revenue | 216.01M |
| Gross Profit | 83.59M |
| Operating Income | -17.68M |
| Pretax Income | -43.74M |
| Net Income | -58.37M |
| EBITDA | -17.68M |
| EBIT | -17.68M |
| Earnings Per Share (EPS) | -0.10 |
Balance Sheet
Qinghai Spring Medicinal Resources Technology Co., Ltd. holds 163.54M in cash and equivalents against 2.61M in total debt, resulting in a net debt position of -162.79M. Total book value stands at 668.75M, with working capital of 596.19M providing operational flexibility.
| Cash & Cash Equivalents | 163.54M |
| Total Debt | 2.61M |
| Net Debt | -162.79M |
| Equity (Book Value) | 668.75M |
| Book Value Per Share | 1.21 |
| Working Capital | 596.19M |
Cash Flow
After subtracting -3.22M in capital expenditures, free cash flow totaled -3.22M - equivalent to -0.01 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -3.22M |
| Free Cash Flow | -3.22M |
| FCF Per Share | -0.01 |
Margins
Qinghai Spring Medicinal Resources Technology Co., Ltd. operates with a gross margin of 38.70, reflecting its pricing power and cost economics. The operating margin of -8.19 and net profit margin of -27.02 provide insight into operational efficiency.
| Gross Margin | 38.70 |
| Operating Margin | -8.19 |
| Pretax Margin | -20.25 |
| Profit Margin | -27.02 |
| EBITDA Margin | -8.19 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.38 |
| FCF Yield | 0.19 |
Stock Splits
Qinghai Spring Medicinal Resources Technology Co., Ltd.'s most recent stock split took place on September 30, 2014 with a 250:31 split ratio.
| Last Split Date | 9/30/2014 |
| Split Ratio | 250:31 |
Scores
Qinghai Spring Medicinal Resources Technology Co., Ltd. posts an Altman Z-Score of 28.81, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 28.81 |